RxKinetics Overview

  • Founded
  • 1997
  • Status
  • Acquired/​Merged
  • Employees
  • 21
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $20M
Latest Deal Amount

RxKinetics General Information


Developer of a drug delivery technologies. The company focuses on developing therapy to treat oral mucositis-mouth sores-in cancer patients.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Primary Office
  • Boulder, CO
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RxKinetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 12-Oct-2006 $20M 0000 Completed Clinical Trials - Phase 2
1. Early Stage VC 01-Jan-1999 Completed Product Development

RxKinetics Former Investors (1)

To view RxKinetics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Partisan Management Group Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial